Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Current Gene Therapy|March 13, 2010
Building better chimeric antigen receptors for adoptive T cell therapyJohn S Bridgeman, Robert E Hawkins, Andreas A Hombach, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2016
Superior Therapeutic Index in Lymphoma Therapy: CD30(+) CD34(+) Hematopoietic Stem Cells Resist a Chimeric Antigen Receptor T-cell AttackAndreas A Hombach, André Görgens, Markus Chmielewski, et al.
British Journal of Cancer|September 11, 2003
An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cellsC Heuser, M Ganser, A Hombach, et al.
Plos One|February 1, 2012
The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cellsGunter Rappl, Tobias Riet, Sabine Awerkiew, et al.
Plos One|October 3, 2012
An IL12-IL2-antibody fusion protein targeting Hodgkin's lymphoma cells potentiates activation of NK and T cells for an anti-tumor attackTobias Jahn, Martin Zuther, Björn Friedrichs, et al.
Cancer Research|March 31, 2001
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysisA Hombach, D Sent, C Schneider, et al.
Gastroenterology|October 10, 1997
T cell targeting of TAG72+ tumor cells by a chimeric receptor with antibody-like specificity for a carbohydrate epitopeA Hombach, C Heuser, R Sircar, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 23, 1997
Specific activation of resting T cells against CA19-9+ tumor cells by an anti-CD3/CA19-9 bispecific antibody in combination with a costimulatory anti-CD28 antibodyA Hombach, T Tillmann, M Jensen, et al.
Gene Therapy|August 6, 1999
A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEAA Hombach, D Koch, R Sircar, et al.
Gene Therapy|June 29, 2000
T cell activation by recombinant FcepsilonRI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognitionA Hombach, C Heuser, M Gerken, et al.
Pageof 8